Fenfluramine HCl (Fintepla(®)) provides long‐term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open‐label extension study

OBJECTIVE: Fenfluramine has been shown to provide clinically meaningful and statistically significant reductions in convulsive seizure frequency in children and adolescents (aged 2‐18 years) with Dravet syndrome in two randomized, placebo‐controlled clinical trials. The objective of this analysis wa...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Epilepsia
Hoofdauteurs: Sullivan, Joseph, Scheffer, Ingrid E., Lagae, Lieven, Nabbout, Rima, Pringsheim, Milka, Talwar, Dinesh, Polster, Tilman, Galer, Bradley, Lock, Michael, Agarwal, Anupam, Gammaitoni, Arnold, Morrison, Glenn, Farfel, Gail
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2020
Onderwerpen:
Full‐length Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7756901/
https://ncbi.nlm.nih.gov/pubmed/33078386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/epi.16722
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items